La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Haemonetics Bilan de santé
Santé financière contrôle des critères 2/6
Haemonetics possède un total de capitaux propres de $905.4M et une dette totale de $1.2B, ce qui porte son ratio d'endettement à 135.1%. Son actif total et son passif total sont $2.5B et de $1.6B. L'EBIT de Haemonetics est $219.2M ce qui fait que son ratio de couverture des intérêts 11.2. Elle dispose de liquidités et de placements à court terme de $346.1M.
Informations clés
135.1%
Ratio d'endettement
US$1.22b
Dette
| Ratio de couverture des intérêts | 11.2x |
| Argent liquide | US$346.07m |
| Fonds propres | US$905.37m |
| Total du passif | US$1.64b |
| Total des actifs | US$2.54b |
Mises à jour récentes de la santé financière
Is Haemonetics (NYSE:HAE) A Risky Investment?
Oct 24
Haemonetics (NYSE:HAE) Has A Rock Solid Balance Sheet
Jul 07Haemonetics (NYSE:HAE) Has A Rock Solid Balance Sheet
Apr 06We Think Haemonetics (NYSE:HAE) Can Manage Its Debt With Ease
Jan 05Haemonetics (NYSE:HAE) Seems To Use Debt Rather Sparingly
Oct 04Here's Why Haemonetics (NYSE:HAE) Can Manage Its Debt Responsibly
Jul 03Recent updates
What You Can Learn From Haemonetics Corporation's (NYSE:HAE) P/E
Aug 14Are Investors Undervaluing Haemonetics Corporation (NYSE:HAE) By 46%?
Jul 18Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth
Jun 21Does Haemonetics (NYSE:HAE) Deserve A Spot On Your Watchlist?
Apr 30Haemonetics Corporation's (NYSE:HAE) Share Price Matching Investor Opinion
Apr 12Haemonetics Corporation (NYSE:HAE) Shares Could Be 35% Below Their Intrinsic Value Estimate
Mar 07Haemonetics Corporation: Improved Performance, Another Bolt-On Deal
Mar 06The Strong Earnings Posted By Haemonetics (NYSE:HAE) Are A Good Indication Of The Strength Of The Business
Feb 15The Price Is Right For Haemonetics Corporation (NYSE:HAE)
Jan 01Haemonetics: Solid Performance Of This Blood Play
Nov 22Here's Why We Think Haemonetics (NYSE:HAE) Might Deserve Your Attention Today
Nov 14Is Haemonetics (NYSE:HAE) A Risky Investment?
Oct 24Haemonetics Offers Relatively Rare Momentum In A Tough Medical Device Environment
Oct 13Haemonetics' Fiscal Q1 2024: Blood, Sweat, And Stellar Gains
Aug 09Here's Why Haemonetics (NYSE:HAE) Has Caught The Eye Of Investors
Aug 09An Intrinsic Calculation For Haemonetics Corporation (NYSE:HAE) Suggests It's 48% Undervalued
Jul 25Haemonetics (NYSE:HAE) Has A Rock Solid Balance Sheet
Jul 07Haemonetics (NYSE:HAE) Has A Rock Solid Balance Sheet
Apr 06Is There An Opportunity With Haemonetics Corporation's (NYSE:HAE) 46% Undervaluation?
Mar 19Haemonetics Executing Well, But Valuation Dogged By Concerns About A Large Customer
Feb 16Haemonetics: Earnings Rate Of Change Justifies High Multiples
Feb 01We Think Haemonetics (NYSE:HAE) Can Manage Its Debt With Ease
Jan 05Is There An Opportunity With Haemonetics Corporation's (NYSE:HAE) 36% Undervaluation?
Dec 15Haemonetics Q2 2023 Earnings Preview
Nov 04Haemonetics (NYSE:HAE) Seems To Use Debt Rather Sparingly
Oct 04Haemonetics: Plasma Thesis Continues To Play Out, Reiterate Buy
Sep 06Haemonetics reaches new 52-week high; shares up 41% YTD
Aug 24Haemonetics reports Q2 earnings beat; raises FY22 guidance
Aug 10A Look At The Intrinsic Value Of Haemonetics Corporation (NYSE:HAE)
Aug 10Here's Why Haemonetics (NYSE:HAE) Can Manage Its Debt Responsibly
Jul 03Haemonetics: Upside Case Hinges On Blood Plasma Collection Market
Jun 11Analyse de la situation financière
Passif à court terme: Les actifs à court terme de HAE ( $978.6M ) dépassent ses passifs à court terme ( $260.1M ).
Passif à long terme: Les actifs à court terme de HAE ( $978.6M ) ne couvrent pas ses passifs à long terme ( $1.4B ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de HAE ( 96.9% ) est considéré comme élevé.
Réduire la dette: Le ratio d'endettement de HAE est passé de 75.3% à 135.1% au cours des 5 dernières années.
Couverture de la dette: La dette de HAE n'est pas bien couverte par le flux de trésorerie opérationnel ( 11.1% ).
Couverture des intérêts: Les paiements d'intérêts de HAE sur sa dette sont bien couverts par l'EBIT ( 11.2 x couverture).